Citius Oncology Inc (CTOR)
1.40
-0.03
(-2.10%)
USD |
NASDAQ |
Sep 27, 16:00
1.40
0.00 (0.00%)
After-Hours: 20:00
Citius Oncology SG&A Expense (Annual)
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
Date | Value |
---|---|
September 30, 2023 | 7.881M |
Date | Value |
---|---|
September 30, 2022 | 1.429M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
1.429M
Minimum
2022
7.881M
Maximum
2023
4.655M
Average
4.655M
Median
SG&A Expense (Annual) Benchmarks
Citius Pharmaceuticals Inc | 21.91M |
NovaBay Pharmaceuticals Inc | 12.83M |
Palatin Technologies Inc | 15.29M |
iBio Inc | 11.67M |
Theriva Biologics Inc | 7.12M |